ATEC241220P2500
- 0.00
- 0.000.00%
Alphatec Newsroom
Alphatec Is Maintained at Overweight by Barclays
Alphatec Holdings Analyst Ratings
Barclays Maintains Alphatec(ATEC.US) With Buy Rating, Raises Target Price to $20
Stifel Maintains Alphatec(ATEC.US) With Buy Rating, Maintains Target Price $15
Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), Avanos Medical (AVNS) and Alphatec Holdings (ATEC)
Morgan Stanley Maintains Alphatec(ATEC.US) With Hold Rating, Raises Target Price to $9.5
Barclays Maintains Alphatec(ATEC.US) With Buy Rating, Maintains Target Price $19
A Quick Look at Today's Ratings for Alphatec(ATEC.US), With a Forecast Between $12 to $22.5
A Quick Look at Today's Ratings for Alphatec(ATEC.US), With a Forecast Between $8 to $22.5
Alphatec Price Target Maintained With a $20.00/Share by HC Wainwright & Co.
Alphatec Holdings Analyst Ratings
Wells Fargo Maintains Alphatec(ATEC.US) With Buy Rating, Maintains Target Price $19
Buy Rating for Alphatec Holdings Amidst Positive Cash Flow Shift and Strategic Financial Goals
Lake Street Maintains Alphatec(ATEC.US) With Buy Rating, Maintains Target Price $18
Lake Street Maintains Alphatec(ATEC.US) With Buy Rating, Maintains Target Price $18
TD Cowen Maintains Alphatec(ATEC.US) With Buy Rating, Maintains Target Price $22.5
Piper Sandler Maintains Alphatec(ATEC.US) With Buy Rating, Cuts Target Price to $12
Piper Sandler Reaffirms Their Buy Rating on Alphatec Holdings (ATEC)
Wells Fargo Maintains Alphatec(ATEC.US) With Buy Rating, Maintains Target Price $19
Buy Rating on Alphatec Holdings Backed by Strong Sales Recruitment and Market Disruption Potential